Analyst consensus rating
Novartis Analyst Rating: Hold
Direct answer
Novartis's consensus rating is Hold.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $154.65.
Forecast evidence checked October 18, 2026.
Get free Novartis email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $150.62
- Average price target
- $154.65
- High price target
- $185.00
- Low price target
- $130.00
- Low target gap
- -13.7%
- Target upside
- +2.7%
- High target gap
- +22.8%
- Target range width
- 36.5%
- Consensus rating
- Hold
- Analysts
- 11
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Novartis?
Novartis has a verified Hold consensus. The same dataset has an average price target of $154.65.
How far are Novartis's low and high targets from the recorded price?
The low target implies -13.7%, while the high target implies +22.8%.
How many analysts are included in Novartis's consensus?
The verified consensus includes 11 analysts.
How is Novartis's target upside or downside calculated?
The average target of $154.65 is divided by the recorded price of $150.62, then one is subtracted to produce +2.7%. This does not guarantee a future return.
When was Novartis's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.